The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
27
No.
41
November 09, 2001
- Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.
- Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.
- Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.
- In Setback For Generics, Court Overturns FDA.
- Advisors Suggest Consortia For Lung Cancer Research.
- Young Elected ACS President, Von eschenback Pres.-Elect.
TCL
Vol.
27
No.
42
November 16, 2001
- House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.
- Kimmel Donates $150 Million To Hopkins For Cancer Research, Patient Residence.
- Harvard’s Harvey Fineberg Is Elected IOM President.
- Pancreatic Cancer Research To Increase, Institute Says.
- American cancer Society Funds 84 Research Grants. NCI, NIGMS To Support Synchrotron Beamlines.
- NIEHS, Five Grantees Form Toxicogenomics Group.
TCL
Vol.
27
No.
43
November 23, 2001
- Advisors Approve Lung Screening Trial Testing Spiral CT Vs. X-Ray, For $200M.
- Cure For Lymphoma Foundation Awards Five; Lefall Honored; AACR Begins New Journal.
- New AACR Journal Avaiable Free Online Until April 15.
- NCI Seeks Nominations For Consumer Liaison Group.
- FDA Seeks Consumers For Advisory Committees.
TCL
Vol.
27
No.
44
November 30, 2001
- NCI Advisors Approve Center Grants For Research On Health Disparities.
- After A One-Month Retirement, Becker Returns To M.D. Anderson As Research Prof.
- Obit: Shirley Lansky, 66, Illinois Cancer Center Director, Dead.
- BSA Approves 3 Concepts For Grants Worth $44 Million.
- US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.
- Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.
- Alexion In Collaboration With Netherlands Center.
- FDA Designates Zometa For Priority Review.
TCL
Vol.
27
No.
45
December 07, 2001
- Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.
- NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center.
- Lurie Center At Northwestern Wins Core Grant Renewal.
- Cancer Rates Keep Falling, NCI’s Progress Report Says.
- Cancer Panel Report Urges Removal Of Barriers To Care.
TCL
Vol.
27
No.
46
December 14, 2001
- Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.
- AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.
- Campus-Dweller Rabson Finds Comfort In NIH Security.
- Endostatin Enters Phase II Trial For Neuroendocrine Tumors.
- Siemens To Provide Technology To DxTx For Lung Cancer Detection.
- Myriad In Partnership To Market Products.
- Computer-Aided Detection Approved For Mammograms.